The Health Sciences Institute is intended to provide cutting-edge health information.
Nothing on this site should be interpreted as personal medical advice. Always consult with your doctor before changing anything related to your healthcare.

This common test can change your life… and not for the better

In a move that can only be described as sheer lunacy, the FDA has stated that it’s probably fine and dandy to allow a heavy metal to accumulate in your brain, bones, and skin.

What’s next? Cigarettes being handed out for kindergarteners along with the milk and cookies?

As part of its “ongoing” review of the risks involved in being injected with a gadolinium-based contrast agent (GBCA) to enhance an MRI scan, the FDA issued “patient medication guides” in late May.

They’re supposed to tell someone who’s about to receive one of these tests all of the details and risks involved in being injected with this heavy metal, and they do… sort of.

But as expected with most anything the FDA does, these guides will leave patients more confused than ever over what they’re about to submit to.

That’s why it’s urgent that you know the whole story before you allow this poison to be put inside your body.

If there were ever a situation where the FDA could have really done something to benefit patients, this was it. But true to form, it acted on the side of industry.

Over the past year, I’ve told you about many of the dangers involved in being injected with a GBCA before undergoing an MRI. European regulators have already suspended three of the most frequently used ones: Omniscan, OptMark, and Magnevist. And most recently, South Korea put a ban on 13 GBCAs — for at least until the end of the year — due to “safety concerns.”

Of course, U.S. doctors and radiologists will sing a different tune, telling you how harmless these dyes are… how your kidneys will excrete them… and how necessary they are to allow for accurate readings of the scans.

But none of that is true!

As HSI panel member Dr. Allan Spreen says, gadolinium dyes are “highly toxic” and used purely for the “convenience” of radiologists.

But here’s the thing — the entire theory that this highly toxic substance is “safe” to inject into us was based on the concept that most, if not all of it, is simply eliminated in our urine. Now we’re being told that gadolinium is known to be “retained in organs.”

If that sounds worrisome to you, well… it should be!

Which brings me back to the FDA and its new patient-medication guides.

If you were to receive one for a GBCA called Omniscan, you would learn the scary facts about how gadolinium will accumulate in your brain, bones, skin, and “other parts of your body for a very long time.” You’d also discover that pain, tiredness, and skin, muscle, or “bone ailments” have been reported by patients, along with how pregnant women and kids are at a bigger risk of retaining this toxin in their bodies.

But that’s only the half of it!

The label for Omniscan also comes along with this same guide, which is not something the average patient would ever get to see. It warns that while the most frequent adverse reactions are nausea, headache, and dizziness, it can also result in an abnormal heart rhythm, heart failure, and the risk of a heart attack.

The FDA’s summary of all of this frightening information is that while “it is not known how gadolinium may affect you,” studies have found it not to be a problem if you have “normal kidneys.”

But what does that mean exactly, and how do we know if our kidney function is considered normal? The guide advises to get your kidneys checked before submitting to an MRI that uses a GBCA – but come on, how many patients are given that option?

And wait until you hear this! The FDA’s “rules” about these guides say that any healthcare professional can withhold one if they think that it’s not “in a patient’s best interest to receive” it.

What! Why even bother to print these up in the first place?

Also mentioned in this guide that you may receive — or just as likely may not — is a condition called nephrongenic system fibrosis (NSF), a horrific skin disease that can make your skin and joints feel and look like wood that can be triggered by a GBCA if you have “kidney problems.”

The bottom line here is that once you find out that a GBCA is going to harm you, it will be too late to do anything about it.

That’s why you need to follow the two steps below faithfully!

1. First and foremost, if you or a family member are scheduled to have an MRI, ask if it will be “enhanced” with a contrasting agent. Dr. Spreen advises that all such dyes be “adamantly refused.”

2. And before you set foot in an imaging facility to have an MRI done, ask your doctor why he ordered it. In many cases, research has found that MRIs (as well as other diagnostic tests) are highly overused and unnecessary.

I know, it can be extremely difficult to question your doctor in a situation such as this. But going along with this charade and pretending there’s nothing wrong with having a heavy metal buildup in your body is like playing Russian roulette.

If you lose, there’s no going back.

“FDA: New med guide for patients receiving gadolinium-based contrast agents” Diana Ernst, May 17, 2018, MPR, empr.com

Get a free copy of 5 Household Items that Cause Cancer

By texting HSI to 844-539-1128, you are providing your electronic signature expressly consenting to be called and texted (including by prerecorded messages, using an autodialer, and/or automated means) with alerts, stories, reports, and marketing communications from Institute of Health Sciences, LLC. and its authorized representatives at the phone number you provide, including landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also consent and unconditionally agree to our Privacy Policy and Terms of Use, including the arbitration provision and class action waiver contained therein. Msg&data rates may apply. 15 Msgs/Month. You are not required to agree to this as a condition of making a purchase.

Terms & Conditions

The following Terms and Conditions apply to your use of the website located at hsionline.com (the “website”) and any text messages that you send to or receive from the Institute of Health Sciences, L.L.C. These Terms and Conditions constitute a binding agreement (“Agreement”) between you (“you”) Institute of Health Sciences, L.L.C (“we”, “us”, etc.)  Please read these terms carefully. 

By providing your telephone number to us, texting us a short code listed on the website, or otherwise indicate your agreement to these Terms and Conditions, you are agreeing to the mandatory arbitration provision and class action waiver below. 

ARBITRATION IS MANDATORY AND THE EXCLUSIVE REMEDY FOR ANY AND ALL DISPUTES RELATED TO THIS WEBSITE, THIS AGREEMENT, AND ANY TELEPHONE CALLS, EMAILS, OR TEXT MESSAGES THAT YOU RECEIVE FROM OR ON BEHALF OF US, UNLESS SPECIFIED BELOW OR UNLESS YOU OPT-OUT.

Text Messaging and Telemarketing Terms and Conditions

When you provide your telephone number on this website or send a text message to us with or from a short-code, you agree to receive alerts and communications, and marketing messages including those sent via automated telephone dialing system, text messages, SMS, MMS, and picture messages from Institute of Health Sciences, L.L.C at the phone number you provide on this website or the phone number from which you text the short code, including on landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also agree to the mandatory arbitration provision and class action waiver below. Your consent is not required to purchase goods or services. Message & data rates may apply.

You may opt-out at any time by texting the word STOP to the telephone number from which you receive the text messages.  Call 1-888-213-0764 to learn more.  By providing your telephone number, you agree to notify us of any changes to your telephone number and update your account us to reflect this change. Your carrier may charge you for text messages and telephone calls that you receive, or may prohibit or restrict certain mobile features, and certain mobile features may be incompatible with your carrier or mobile device. Contact your carrier with questions regarding these issues.

Dispute Resolution by Binding Arbitration and Class Action Waiver

Any dispute relating in any way to telephone calls, emails, or text messages that you receive from or on behalf of Institute of Health Sciences, L.L.C this website, or this Agreement (collectively “Disputes”) shall be submitted to confidential arbitration and shall be governed exclusively by the laws of the State of Maryland, excluding its conflict of law provisions.  For the avoidance of doubt, all claims arising under the Telephone Consumer Protection Act and state telemarketing laws shall be considered “Disputes” that are subject to resolution by binding individual, confidential arbitration.

If a Dispute arises under this Agreement, you agree to first contact us at 1-888-213-0764 or help@hsionline.com. Before formally submitting a Dispute to arbitration, you and we may choose to informally resolve the Dispute.  If any Dispute cannot be resolved informally, you agree that any and all Disputes, including the validity of this arbitration clause and class action waiver, shall be submitted to final and binding arbitration before a single arbitrator of the American Arbitration Association (“AAA”) in a location convenient to you or telephonically. Either you or we may commence the arbitration process by submitting a written demand for arbitration with the AAA, and providing a copy to the other party.  The arbitration will be conducted in accordance with the provisions of the AAA’s Commercial Dispute Resolutions Procedures, Supplementary Procedures for Consumer-Related Disputes, in effect at the time of submission of the demand for arbitration.  Except as may be required by law as determined by the arbitrator, no party or arbitrator may disclose the existence, content or results of any arbitration hereunder without the prior written consent of both parties. Institute of Health Sciences, L.L.C will pay all of the filing costs.  Without limiting the foregoing, YOU EXPRESSLY AGREE TO SUBMIT TO ARBITRATION ALL DISPUTES RELATING TO ANY TEXT MESSAGES OR TELEPHONE CALLS YOU RECEIVE FROM OR ON BEHALF OF US OR ANY ENTITY WITH WHOM WE MAY SHARE YOUR TELEPHONE NUMBER.  Further, we both agree that all entities with whom we share your telephone numbers shall be third party beneficiaries of this Agreement to Arbitrate Disputes, and that those entities have the same rights as Institute of Health Sciences, L.L.C to enforce this arbitration provision.

Notwithstanding the foregoing, the following shall not be subject to arbitration and may be adjudicated only in the state and federal courts of Maryland: (i) any dispute, controversy, or claim relating to or contesting the validity of our or one of our family company’s intellectual property rights and proprietary rights, including without limitation, patents, trademarks, service marks, copyrights, or trade secrets; (ii) an action by us for temporary or preliminary injunctive relief, whether prohibitive or mandatory, or other provisional relief; (iii) any legal action by us against a non-consumer; or (iv) interactions with governmental and regulatory authorities.  You expressly agree to refrain from bringing or joining any claims in any representative or class-wide capacity, including but not limited to bringing or joining any claims in any class action or any class-wide arbitration.

The arbitrator’s award shall be binding and may be entered as a judgment in any court of competent jurisdiction. To the fullest extent permitted by applicable law, no arbitration under this Agreement may be joined to an arbitration involving any other party subject to this Agreement, whether through a class action, private attorney general proceeding, class arbitration proceedings or otherwise.

YOU UNDERSTAND THAT YOU WOULD HAVE HAD A RIGHT TO LITIGATE IN A COURT, TO HAVE A JUDGE OR JURY DECIDE YOUR CASE AND TO BE PARTY TO A CLASS OR REPRESENTATIVE ACTION.  HOWEVER, YOU UNDERSTAND AND AGREE TO HAVE ANY CLAIMS DECIDED INDIVIDUALLY AND ONLY THROUGH ARBITRATION.  You shall have thirty (30) days from the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, to opt out of this arbitration agreement, by contacting us by email at help@hsionline.com or by mail Health Sciences Institute, PO Box 913, Frederick, MD 21705-0913. If you do not opt out by the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, then you are not eligible to opt out of this arbitration agreement.

Electronic Signatures

All information communicated on the website is considered an electronic communication.  When you communicate with us through or on the website, by text message or telephone, or via other forms of electronic media, such as e-mail, you are communicating with us electronically.  You agree that we may communicate electronically with you and that such communications, as well as notices, disclosures, agreements, and other communications that we provide to you electronically, are equivalent to communications in writing and shall have the same force and effect as if they were in writing and signed by the party sending the communication.

You further acknowledge and agree that by clicking on a button labeled “ORDER NOW”, “SUBMIT”, “I ACCEPT”, “I AGREE”, “YES”, by texting a short code to us in response to a request on this website, or by clicking or similar links or buttons, you are submitting a legally binding electronic signature and are entering into a legally binding contract.  You acknowledge that your electronic submissions constitute your agreement and intent to be bound by this Agreement.  Pursuant to any applicable statutes, regulations, rules, ordinances or other laws, including without limitation the United States Electronic Signatures in Global and National Commerce Act, P.L. 106-229 (the “E-Sign Act”) or other similar statutes, YOU HEREBY AGREE TO THE USE OF ELECTRONIC SIGNATURES, CONTRACTS, ORDERS AND OTHER RECORDS AND TO ELECTRONIC DELIVERY OF NOTICES, POLICIES AND RECORDS OF TRANSACTIONS INITIATED OR COMPLETED THROUGH THE WEBSITE.  Furthermore, you hereby waive any rights or requirements under any statutes, regulations, rules, ordinances or other laws in any jurisdiction which require an original signature, delivery or retention of non-electronic records, or to payments or the granting of credits by other than electronic means You may receive a physical paper copy of this contract by contacting us at help@hsionline.com.

Privacy Policy

Please read our Privacy Policy, which is incorporated herein by reference.  In the event of any conflict between these Terms and Conditions and the Privacy Policy, these Terms shall control.

Contact Us

You may contact us by telephone at 1-888-213-0764 or by email at help@hsionline.com.